• DOI:10.1016/S0387-7604(01)00349-7
Corpus ID: 23240417

Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study

@article{Gorbachevskaya2001CerebrolysinTI,
  title={Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study},
  author={N. Gorbachevskaya and V. Bashina and Vitali V. Gratchev and A. Iznak},
  journal={Brain and Development},
  year={2001},
  volume={23},
  pages={s90-s93}
}

N. Gorbachevskaya, V. Bashina, +1 author A. Iznak

Published 2001

Medicine

Brain and Development

Based on the suggestion that nerve growth factor plays a core role in the brain maturation process, which is altered in Rett syndrome, we investigate the influence of Cerebrolysin--the brain-derived peptidergic drug - on motor and higher cortical functions in Rett syndrome girls. The open pilot study was performed on nine Rett syndrome girls (aged from 2 years and 2 months to 7 years and 6 months) at stage 3 of the illness, and included both clinical and quantitative EEG evaluations before and… CONTINUE READING

View on Elsevier

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed